Study of drug-resistant TB types in Central Africa
Part of Infections, Injuries & trauma clinical trials.
This study looks at the types of drug-resistant tuberculosis (TB) bacteria spreading in Central Africa. By examining sputum samples from people with TB, researchers hope to better understand how resistant strains are transmitted, which can help improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 8 years old or older and able to provide a sputum (phlegm) sample.
- You must have tested positive for tuberculosis using a rapid test called GeneXpert.
- You should be located in a Central African country for treatment and sample collection.
- You may already be part of a related TB epidemiology study, which could make enrollment easier.
- Your sputum sample must be of sufficient quality and quantity for lab testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how tuberculosis bacteria might resist treatment. It studies people who test positive for TB using a GeneXpert test, both in the lungs and other body parts.
This trial is for people newly diagnosed with tuberculosis (TB) and looks at how TB bacteria can become resistant to multiple drugs. It will help doctors understand which treatments work best for new TB patients.
This trial tests whether using results from a detailed sputum (phlegm) test to tailor treatment improves outcomes in people with drug-resistant (rifampicin-resistant) pulmonary TB. It may help you get the most appropriate regimen based on your specific test results.
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
This study looks for antibiotic-resistant bacteria in the blood of patients with a suspected bloodstream infection. The goal is to understand which antibiotics still work, helping doctors choose the right treatment.
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
Hear when a new Strains trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.